Imed Infinity Medical-Limited Partnership Stock
Equities
IMED
IL0011712309
Investment Holding Companies
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
97.9 ILa | +2.94% | +3.38% | -14.27% |
Sales 2022 | 0.2 73.96 | Sales 2023 | -0.94 -348.35 | Capitalization | 1.28M 472M |
---|---|---|---|---|---|
Net income 2022 | -1M -370M | Net income 2023 | -1M -370M | EV / Sales 2022 | -2,846,670 x |
Net cash position 2022 | 2.21M 816M | Net cash position 2023 | 1.55M 572M | EV / Sales 2023 | 287,923 x |
P/E ratio 2022 |
-1.62
x | P/E ratio 2023 |
-0.72
x | Employees | 55 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
1 day | +2.94% | ||
1 week | +3.38% | ||
Current month | -0.61% | ||
1 month | -3.83% | ||
3 months | +65.37% | ||
6 months | +55.40% | ||
Current year | -14.27% |
Managers | Title | Age | Since |
---|---|---|---|
Itay Gal-Or
CEO | Chief Executive Officer | 40 | 22-11-20 |
Hanan Morris
DFI | Director of Finance/CFO | 58 | 20-09-28 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 21-08-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Suesskind
BRD | Director/Board Member | 80 | 21-08-14 |
Shuky Abramowitz
CHM | Chairman | 63 | 20-12-16 |
Yahel Shachar
BRD | Director/Board Member | 62 | 21-03-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 97.9 | +2.94% | 7,707 |
24-06-09 | 95.1 | -1.96% | 11,770 |
24-06-05 | 97 | +2.43% | 5,801 |
24-06-04 | 94.7 | -3.56% | 48,933 |
Delayed Quote TEL AVIV STOCK EXCHANGE, June 10, 2024 at 10:24 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-14.27% | 1.07M | |
+23.71% | 82.91B | |
+14.03% | 18.06B | |
+52.82% | 16.86B | |
+10.43% | 14.85B | |
-3.32% | 12.48B | |
+1.93% | 11.22B | |
+9.09% | 11.16B | |
+24.87% | 9.85B | |
-3.82% | 9.46B |
- Stock Market
- Equities
- IMED Stock